Joint Health Portfolio

The Joint Health Portfolio from Boehringer Ingelheim Vetmedica Inc., with products including Vetalog®, Surpass®, Hyvisc® and Hyalovet®, gives veterinarians a range of options to treat joint pain. Our products use advanced technology to help keep equine athletes competing, making us your point of contact for joint health.

Advanced technology for equine joint pain

  • Unique topical delivery stays where applied and directly reduces
    pain and inflammation at its source1
    • Always wear gloves when administering SURPASS
  • Local application can reduce lameness while decreasing the risks of the side effects that can occur with other systemic pain relievers1
  • Multi-joint capability: hock, knee, fetlock, pastern1
  • Only FDA-approved diclofenac for veterinary use

Like any medication, non-steroidal anti-inflammatory drugs (NSAIDs) such as SURPASS may cause side effects. These are usually mild and affect primarily the gastrointestinal system, but more serious side effects can occur. NSAIDs should only be administered under the direction of a licensed professional. SURPASS topical cream is only approved for use in horses and has not been evaluated in breeding, pregnant, or lactating horses, or in horses under 1 year of age. Do not exceed the recommended dose. Wear gloves when administering SURPASS. If direct contact with skin occurs, wash immediately with soap and water. Please refer to the package insert for complete product information.

Believe in Victory

  • High molecular weight hyaluronic acid
  • Extremely pure
  • No known contraindications
  • One convenient injection
  • FDA-approved for intra-articular injection with a high margin of safety

A mild, transparent post-injection inflammatory response may occur. For intra-articular injection in horses only. Do not use in horses intended for food.

Track record of consistent performance

  • A single injection of HYALOVET has been shown to significantly reduce lameness, swelling, pain, heat and pain on joint flexion associated with acute synovitis of the carpal joint2 
  • 2 mL vials and 2 mL syringes
  • No refrigeration required — stores at room temperature 
  • FDA-approved, economic hyaluronic acid

As with any intra-articular injection, a mild inflammatory response may be seen in the joint following HYALOVET injection. The response in self-limiting but may last from 2 to 5 days after treatment. If inflammation is excessive or severe, the possibility of infection should be considered and appropriate antibiotic therapy instituted.

Fast pain relief

  • Reduces pain and improves motion within 24 hours
  • Reaches maximum effective levels in synovial fluid within 24 hours of intra-articular injection
  • Can be used intramuscularly, intra-articularly or intrasynovially
  • Choose from 2 mg/mL or 6 mg/mL presentations
  • FDA-approved corticosteroid

As with all corticosteroids, Vetalog should be used with care in all stages of pregnancy. Do not use with viral infections. Please see full product safety information. Following intra-articular administration, pain and other local symptoms may continue for a short time before effective relief is obtained.

1. SURPASS® (1% diclofenac sodium) Freedom of Information Summary, Greensboro, NC: IDEXX Pharmaceuticals, Inc; 2004.
2. Hyalovet® (hyaluronate sodium) Freedom of Information Summary; Fort Dodge, IA, Fort Dodge Laboratories; 1988.

SURPASS, HYALOVET and VETALOG are registered trademarks and WISDOM is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, licensed to Boehringer Ingelheim Vetmedica, Inc.

HYVISC is a registered trademark of Anika Therapeutics, Inc.

©2015 Boehringer Ingelheim Vetmedica, Inc. HYVI-011428A